Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents

Background: In more than 90% of chronic viral hepatitis C (HCV) patients treated with direct-acting antiviral agents (DAAs), a sustained viral response (SVR) was observed. Unfortunately, there are subgroups of subjects who display enduring liver fibrosis and are at high risk of developing hepatocell...

Descripción completa

Detalles Bibliográficos
Autores principales: Cossiga, Valentina, La Civita, Evelina, Bruzzese, Dario, Guarino, Maria, Fiorentino, Andrea, Sorrentino, Rosanna, Pontillo, Giuseppina, Vallefuoco, Luca, Brusa, Stefano, Montella, Emma, Terracciano, Daniela, Morisco, Filomena, Portella, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428144/
https://www.ncbi.nlm.nih.gov/pubmed/36059971
http://dx.doi.org/10.3389/fphar.2022.891398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428144/
https://www.ncbi.nlm.nih.gov/pubmed/36059971
http://dx.doi.org/10.3389/fphar.2022.891398

Ejemplares similares